BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 343117)

  • 1. Inhibition of human platelet aggregation by stable analogs of prostacyclin.
    Togna G; GAndolfi C; Andreoni A; Fumagalli A; Passarotti C; Faustini F; Patrono C
    Pharmacol Res Commun; 1977 Nov; 9(10):909-16. PubMed ID: 343117
    [No Abstract]   [Full Text] [Related]  

  • 2. Novel 7-oxabicyclo[2.2.1]heptane prostacyclin agonists.
    Haslanger MF; Sprague PW; Snitman D; Vu T; Harris DN; Greenberg R; Powell J
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():293-7. PubMed ID: 6221540
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of the activities of prostacyclin and its stable analogs on the platelet aggregation and cardiovascular systems.
    Kawasaki A; Ishii K; Wakitani K; Tsuboshima M
    Adv Prostaglandin Thromboxane Res; 1980; 6():331-6. PubMed ID: 6992531
    [No Abstract]   [Full Text] [Related]  

  • 4. A new stable prostacyclin mimic, 7-oxoprostaglandin I2.
    Kovács G; Simonidesz V; Tömösközi I; Körmöczy P; Székely I; Papp-Behr A; Stadler I; Szekeres L; Papp G
    J Med Chem; 1982 Feb; 25(2):105-7. PubMed ID: 7035669
    [No Abstract]   [Full Text] [Related]  

  • 5. The relative activity of prostacyclin (PGI2) and a stable analogue 6beta-PGI1 on the gastrointestinal and cardiovascular systems.
    Whittle BJ; Boughton-Smith NK; Moncada S; Vane JR
    J Pharm Pharmacol; 1978 Sep; 30(9):597-9. PubMed ID: 29109
    [No Abstract]   [Full Text] [Related]  

  • 6. Carbacyclin--a potent stable prostacyclin analogue for the inhibition of platelet aggregation.
    Whittle BJ; Moncada S; Whiting F; Vane JR
    Prostaglandins; 1980 Apr; 19(4):605-27. PubMed ID: 6992234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 20-Methyl-prostacyclin analogs--a two stage screening procedure for biological properties.
    Gandolfi CA; Gryglewski RJ
    Pharmacol Res Commun; 1978 Nov; 10(10):885-96. PubMed ID: 366628
    [No Abstract]   [Full Text] [Related]  

  • 8. Generation of prostacyclin by lungs in vivo and its release into the arterial circulation.
    Gryglewski RJ; Korbut R; Ocetkiewicz A
    Nature; 1978 Jun; 273(5665):765-7. PubMed ID: 351417
    [No Abstract]   [Full Text] [Related]  

  • 9. Syntheses and biological activities of some prostacyclin analogs.
    Ohuchida S; Hashimoto S; Wakatsuka H; Arai Y; Hayashi M
    Adv Prostaglandin Thromboxane Res; 1980; 6():337-40. PubMed ID: 6992532
    [No Abstract]   [Full Text] [Related]  

  • 10. Vasodilation and inhibition of platelet aggregation by prostacyclins with modified omega-side chain.
    Schölkens BA; Bartmann W; Beck G; Lerch U; Konz E; Weithmann U
    Prostaglandins Med; 1979 Jul; 3(1):7-22. PubMed ID: 399529
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis of a highly potent analogue of prostacyclin, (-)-5-methyleneisocarbacyclin.
    Amemiya S; Koyama K; Saito S; Kojima K
    Chem Pharm Bull (Tokyo); 1986 Oct; 34(10):4403-5. PubMed ID: 3549013
    [No Abstract]   [Full Text] [Related]  

  • 12. Prostaglandins as inhibitors of human platelet aggregation.
    Di Minno G; Silver MJ; de Gaetano G
    Br J Haematol; 1979 Dec; 43(4):637-47. PubMed ID: 393296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of prostaglandin I2 and analogs on platelet aggregation and smooth muscle contraction.
    Crane BH; Maish TL; Maddox YT; Corey EJ; Székely I; Ramwell PW
    J Pharmacol Exp Ther; 1978 Jul; 206(1):132-8. PubMed ID: 351171
    [No Abstract]   [Full Text] [Related]  

  • 14. Platelet sensitivity to prostacyclin in pregnancy and uterine cancer.
    Briel RC; Lippert TH
    Eur J Obstet Gynecol Reprod Biol; 1981 Jun; 12(1):19-23. PubMed ID: 7018952
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The generation of TXA2 in human platelet rich plasma and its inhibition by nictindole and prostacyclin.
    Grodzińska L; Marcinkiewicz E
    Pharmacol Res Commun; 1979 Feb; 11(2):133-46. PubMed ID: 375247
    [No Abstract]   [Full Text] [Related]  

  • 16. [Prostaglandins and arteriosclerosis. Action of PGI 2 (PGX) on platelet aggregation].
    Messini M; Messini F
    Clin Ter; 1979 Jul; 90(1):3-9. PubMed ID: 394908
    [No Abstract]   [Full Text] [Related]  

  • 17. Prostaglandins E1 and E2, but neither prostacyclin nor prostaglandin D2 have anti-aggregating activity in chicken blood.
    Bult H; Wechsung E; Houvenaghel A; Herman AG
    Arch Int Pharmacodyn Ther; 1981 Feb; 249(2):306-8. PubMed ID: 7013724
    [No Abstract]   [Full Text] [Related]  

  • 18. Effect of prostacyclin on platelet-activating factor induced rabbit and platelet aggregation.
    Bussolino F; Camussi G
    Prostaglandins; 1980 Nov; 20(5):781-91. PubMed ID: 6258196
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The antiplatelet activity of immobilized prostacyclin.
    Ebert CD; Lee ES; Kim SW
    J Biomed Mater Res; 1982 Sep; 16(5):629-38. PubMed ID: 6752148
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 20-Methylprostacyclin: a powerful 'unnatural' platelet aggregation inhibitor.
    van Dorp DA; van Evert WC; van der Wolf L
    Prostaglandins; 1978 Dec; 16(6):953-5. PubMed ID: 373021
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.